Sera Prognostics
Salt Lake City, Utah, United States
Sera Prognostics is a leading women’s health company utilizing our proprietary proteomics and bioinformatics platform to discover, develop and commercialize clinically meaningful and economically impactful biomarker tests, with an initial focus on improving pregnancy outcomes. Sera’s vision is to deliver pivotal and actionable information to pregnant women, their physicians and healthcare payers to significantly improve maternal and neonatal health and to dramatically reduce healthcare costs. Sera’s first commercial product, the PreTRM® Test, is the only broadly clinically validated, commercially available blood-based biomarker test to accurately predict the risk of preterm birth.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2008
- Website
- www.sera.com/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of Sera Prognostics?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now